Effect of disease duration in a randomized phase III trial of rintatolimod, an immune modulator for ME/CFS
Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by David R Strayer, Diane Young, William M Mitchell in…